Alternating R ‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma

This study was registered at GovTrial (clinicaltrials.gov) NCT03054883.

Source: Hematological Oncology - September 1, 2017 Category: Hematology Authors: Pavel Klener, Eva Fronkova, David Belada, Kristina Forsterova, Robert Pytlik, Marketa Kalinova, Martin Simkovic, David Salek, Heidi Mocikova, Vit Prochazka, Petra Blahovcova, Andrea Janikova, Jana Markova, Ales Obr, Adela Berkova, Jozef Kubinyi, Martina V Tags: ORIGINAL RESEARCH ARTICLE Source Type: research